Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.
Pleco Therapeutics has raised $17.2M in total funding. The most recent round was Series A. The last funding was announced in September 2022.
Pleco Therapeutics's investors include Hyloris Pharmaceuticals, OostNL, Netherlands Enterprise Agency.
Pleco Therapeutics is headquartered in Nijmegen, The Netherlands.
Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.
Pleco Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pleco Therapeutics — Funding & Investors." VCBacked, September 5, 2022, https://www.vcbacked.co/company/pleco-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Pleco Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pleco-therapeutics
{{cite web |title=Pleco Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pleco-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated